Systematic investigation of disease- and genotype-specific vulnerabilities in primary blood cancer using high-throughput ex vivo drug screening

Ähnliche Einträge

• Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
  von: Andersson, Emma I., et al.
  Veröffentlicht: (2018)
• IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening
  von: Pohly, Marcel, et al.
  Veröffentlicht: (2025)
• High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas
  von: Herter, Sonja, et al.
  Veröffentlicht: (2025)
• Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling
  von: Batzilla, Alina, et al.
  Veröffentlicht: (2022)
• On-column reaction set-up for high-throughput screenings and mechanistic investigations
  von: Stockinger, Skrollan Carina, et al.
  Veröffentlicht: (2015)